{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:33:17Z","timestamp":1793338397054,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2022-06725"],"award-info":[{"award-number":["2022-06725"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115300","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:52:42Z","timestamp":1787640762000},"page":"115300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Absorption from 3D-printed pediatric carvedilol tablets: insights from in vitro, in vivo, and in silico approaches"],"prefix":"10.1016","volume":"399","author":[{"given":"Lidia","family":"Habtemikael","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksei","family":"Kabedev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Paulsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Liminga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustaf","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn R.","family":"McCain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber S.","family":"Jannach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory T.","family":"Knipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel A.S.","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.115300_bb0005","unstructured":"EMA. European Medicines Agency [Text] [Internet]. 2018 [cited 2022 Dec 13]. Needs for Paediatric Medicines. Available from: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/paediatric-medicines\/needs-paediatric-medicines."},{"key":"10.1016\/j.jconrel.2026.115300_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114483","article-title":"Pediatric oral extemporaneous preparations and practices: International Pharmaceutical Federation (FIP) global study","volume":"204","author":"Fadda","year":"2024","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115300_bb0020","author":"S\u00f6k l\u00e4kemedelsfakta"},{"key":"10.1016\/j.jconrel.2026.115300_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112576","article-title":"Manipulations and age-appropriateness of oral medications in pediatric oncology patients in Sweden: need for personalized dosage forms","volume":"146","author":"Johannesson","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115300_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/pharmaceutics13101676","article-title":"Manipulations of oral medications in paediatric neurology and oncology care at a Swedish University Hospital: health professionals\u2019 attitudes and sources of information","volume":"13","author":"Kader","year":"2021","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115300_bb0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/apa.13700","article-title":"Manipulating tablets and capsules given to hospitalised children in Norway is common practice","volume":"106","author":"Bjerknes","year":"2017","journal-title":"Acta Paediatr."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115300_bb0045","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/apa.14718","article-title":"Manipulation of oral medication for children by parents and nurses occurs frequently and is often not supported by instructions","volume":"108","author":"van der Vossen","year":"2019","journal-title":"Acta Paediatr."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0050","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2018.04.054","article-title":"How close is the dose? Manipulation of 10\u00a0mg hydrocortisone tablets to provide appropriate doses to children","volume":"545","author":"Watson","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115300_bb0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.addr.2016.03.001","article-title":"A new chapter in pharmaceutical manufacturing: 3D-printed drug products","author":"Norman","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115300_bb0060","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s11095-025-03911-6","article-title":"Assessment of a semi-solid extrusion based compounding system solution for personalized ondansetron dosage forms combined with Raman spectroscopy analysis","volume":"42","author":"Bahman","year":"2025","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.115300_bb0065","article-title":"Benchmarking pharmaceutical quality and manufacturing costs of 3D printing against conventional compounding methods for personalization of medicine","volume":"212","author":"AyyoubiS","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s43441-022-00436-7","article-title":"Magistral compounding with 3D printing: a promising way to achieve personalized medicine","volume":"57","author":"Beer","year":"2023","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.jconrel.2026.115300_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107340","article-title":"A risk-based, QTPP-driven framework for semi-solid extrusion 3D printing of personalized medicines: integrating hospital compounding and clinical trial regulation","volume":"216","author":"Annereau","year":"2026","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115300_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119545","article-title":"Tailored pediatric clonazepam tablets produced by 3D printing: meeting quality standards and improving permeation","volume":"200","author":"Habtemikael","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.115300_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120304","article-title":"3D-printing of solid lipid tablets from emulsion gels","volume":"597","author":"Johannesson","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115300_bb0090","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jcis.2023.07.055","article-title":"Synergistic stabilization of emulsion gel by nanoparticles and surfactant enables 3D printing of lipid-rich solid oral dosage forms","volume":"650","author":"Johannesson","year":"2023","journal-title":"J. Colloid Interface Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115300_bb0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1208\/s12249-008-9055-7","article-title":"Carvedilol: Solubilization and cyclodextrin complexation: a technical note","volume":"9","author":"Loftsson","year":"2008","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0100","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1038\/s41598-017-03097-x","article-title":"Fused deposition modeling (FDM) 3D printed tablets for intragastric floating delivery of domperidone","volume":"7","author":"Chai","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115300_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120222","article-title":"3D printed extended release tablets for once daily use: an in vitro and in vivo evaluation study for a personalized solid dosage form","volume":"596","author":"G\u00fcltekin","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115300_bb0110","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1021\/acs.molpharmaceut.2c00306","article-title":"Very-rapidly dissolving printlets of isoniazid manufactured by SLS 3D printing: in vitro and in vivo characterization","volume":"19","author":"Khuroo","year":"2022","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115300_bb0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1208\/s12249-024-02935-2","article-title":"Development, pharmacokinetics and antimalarial evaluation of dose flexible 3D printlets of Dapsone for pediatric patients","volume":"25","author":"Khan","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115300_bb0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1208\/s12249-023-02544-5","article-title":"Development of 3D DLP printed sustained release ibuprofen tablets and their pharmacokinetic evaluation in rats","volume":"24","author":"Mosley-Kellum","year":"2023","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2026.115300_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.105008","article-title":"Improving the quality and clinical efficacy of subdivided levothyroxine sodium tablets by 3D printing technology","volume":"89","author":"Liu","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.115300_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105293","article-title":"Preparation and application of subdivided tablets using 3D printing for precise hospital dispensing","volume":"149","author":"Zheng","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115300_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118497","article-title":"Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: first single-centre, prospective, crossover study in patients","volume":"567","author":"Goyanes","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.115300_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124140","article-title":"Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders","volume":"657","author":"Rodr\u00edguez-Pombo","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115300_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/pharmaceutics12111100","article-title":"I spy with my little eye: a paediatric visual preferences survey of 3D printed tablets","volume":"12","author":"Januskaite","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115300_bb0150","article-title":"Development of 3D printed dexamethasone chewable tablets for prophylaxis of chemotherapy-induced nausea and vomiting in children","volume":"10","author":"Dadkhah","year":"2025","journal-title":"Int. J. Pharm. X"},{"key":"10.1016\/j.jconrel.2026.115300_bb0155","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejpb.2018.04.007","article-title":"3D printed, controlled release, tritherapeutic tablet matrix for advanced anti-HIV-1 drug delivery","volume":"138","author":"Siyawamwaya","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115300_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124668","article-title":"Fabrication of osmotic pump tablets utilizing semisolid extrusion three-dimensional printing technology","volume":"665","author":"Chen","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115300_bb0165","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/pharmaceutics13101733","article-title":"Development of multi-compartment 3D-printed tablets loaded with self-nanoemulsified formulations of various drugs: a new strategy for personalized medicine","volume":"13","author":"Ahmed","year":"2021","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115300_bb0170","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1021\/acs.molpharmaceut.3c00049","article-title":"Molecular dynamics simulation studies of bile, bile salts, lipid-based drug formulations, and mRNA\u2013lipid nanoparticles: a review","volume":"20","author":"Guruge","year":"2023","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115300_bb0175","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1021\/acs.molpharmaceut.6b00888","article-title":"Computational models of the gastrointestinal environment. 1. The effect of digestion on the phase behavior of intestinal fluids","volume":"14","author":"Birru","year":"2017","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115300_bb0180","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1021\/acs.molpharmaceut.6b00887","article-title":"Computational models of the gastrointestinal environment. 2. Phase behavior and drug solubilization capacity of a type I lipid-based drug formulation after digestion","volume":"14","author":"Birru","year":"2017","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115300_bb0185","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s11095-021-03099-5","article-title":"Molecular dynamics simulations and experimental results provide insight into clinical performance differences between Sandimmune\u00ae and Neoral\u00ae lipid-based formulations","volume":"38","author":"Warren","year":"2021","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115300_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030101","article-title":"Relative contributions of solubility and mobility to the stability of amorphous solid dispersions of poorly soluble drugs: a molecular dynamics simulation study","volume":"10","author":"Brunsteiner","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115300_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106639","article-title":"Analysis of stabilization mechanisms in \u03b2-lactoglobulin-based amorphous solid dispersions by experimental and computational approaches","volume":"192","author":"Zhuo","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0200","doi-asserted-by":"crossref","first-page":"17386","DOI":"10.1038\/s41598-024-68362-2","article-title":"Examine stability polyvinyl alcohol-stabilized nanosuspensions to overcome the challenge of poor drug solubility utilizing molecular dynamic simulation","volume":"14","author":"Abdollahi","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115300_bb0205","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejpb.2019.02.007","article-title":"Molecular simulation as a computational pharmaceutics tool to predict drug solubility, solubilization processes and partitioning","volume":"137","author":"Hossain","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0210","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.xphs.2020.10.061","article-title":"Molecular dynamics simulations reveal membrane interactions for poorly water-soluble drugs: impact of bile solubilization and drug aggregation","volume":"110","author":"Kabedev","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0215","doi-asserted-by":"crossref","first-page":"9512","DOI":"10.1038\/s41467-025-64891-0","article-title":"Permeation enhancer-induced membrane defects assist the oral absorption of peptide drugs","volume":"16","author":"Colston","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115300_bb0220","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1208\/s12248-013-9482-6","article-title":"Assessment of juvenile pigs to serve as human pediatric surrogates for preclinical formulation pharmacokinetic testing","volume":"15","author":"Roth","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2026.115300_bb0225","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019 drug delivery systems","volume":"11","author":"Pouton","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115300_bb0230","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jps.10329","article-title":"Separation and characterization of the colloidal phases produced on digestion of common formulation lipids and assessment of their impact on the apparent solubility of selected poorly water-soluble drugs","volume":"92","author":"Kossena","year":"2003","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115300_bb0235","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1002\/jps.23205","article-title":"Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations","volume":"101","author":"Williams","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2026.115300_bb0240","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1021\/acs.molpharmaceut.8b00699","article-title":"Impact of drug physicochemical properties on lipolysis-triggered drug supersaturation and precipitation from lipid-based formulations","volume":"15","author":"Alsk\u00e4r","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115300_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123413","article-title":"Quality attributes for printable emulsion gels and 3D-printed tablets: towards production of personalized dosage forms","volume":"646","author":"Johannesson","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115300_bb0250","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acs.molpharmaceut.8b00811","article-title":"Lipolysis-permeation setup for simultaneous study of digestion and absorption in vitro","volume":"16","author":"Keemink","year":"2019","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115300_bb0255","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11095-020-02833-9","article-title":"Suitability of artificial membranes in lipolysis-permeation assays of oral lipid-based formulations","volume":"37","author":"Hedge","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.115300_bb0260","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jconrel.2019.04.038","article-title":"Effect of lipids on absorption of carvedilol in dogs: is coadministration of lipids as efficient as a lipid-based formulation?","volume":"304","author":"Alsk\u00e4r","year":"2019","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0265","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1208\/s12249-020-01891-x","article-title":"Development of a pediatric mini-tablet formulation for expedited preclinical studies","volume":"22","author":"Lavan","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115300_bb0270","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7120\/09627286.21.2.197","article-title":"Plasma cortisol and noradrenalin concentrations in pigs: automated sampling of freely moving pigs housed in the PigTurn\u00ae versus manually sampled and restrained pigs","volume":"21","author":"Marchant-Forde","year":"2012","journal-title":"Anim. Welf."},{"key":"10.1016\/j.jconrel.2026.115300_bb0275","author":"Tillv\u00e4xtkurvor"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115300_bb0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.jconrel.2026.115300_bb0285","doi-asserted-by":"crossref","DOI":"10.1097\/00005344-198710004-00015","article-title":"Pharmacokinetics and disposition of carvedilol in humans","volume":"10","author":"Neugebauer","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115300_bb0290","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10337-022-04154-y","article-title":"Simultaneous determination of carvedilol, enalaprilat, and perindoprilat in human plasma using LC\u2013MS\/MS and its application to a pharmacokinetic pilot study","volume":"85","author":"Joubert","year":"2022","journal-title":"Chromatographia"},{"key":"10.1016\/j.jconrel.2026.115300_bb0295","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0300","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1021\/ct300646g","article-title":"Improved parameters for the martini coarse-grained protein force field","volume":"9","author":"de Jong","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115300_bb0305","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1021\/acs.molpharmaceut.7b00397","article-title":"Molecular structuring and phase transition of lipid-based formulations upon water dispersion: a coarse-grained molecular dynamics simulation approach","volume":"14","author":"Larsson","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.115300_bb0310","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jconrel.2024.06.008","article-title":"Drug solubilization in dog intestinal fluids with and without administration of lipid-based formulations","volume":"371","author":"Parrow","year":"2024","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115300_bb0315","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1021\/acs.jctc.5b00209","article-title":"Computational Lipidomics with insane: a versatile tool for generating custom membranes for molecular simulations","volume":"11","author":"Wassenaar","year":"2015","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115300_bb0320","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0325","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.apsb.2018.07.004","article-title":"Exploring the utility of the Chasing Principle: influence of drug-free SNEDDS composition on solubilization of carvedilol, cinnarizine and R3040 in aqueous suspension","volume":"9","author":"Siqueira J\u00f8rgensen","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.115300_bb0330","author":"PubChem"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115300_bb0340","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1021\/acs.jctc.5b00513","article-title":"CHARMM-GUI martini maker for coarse-grained simulations with the martini force field","volume":"11","author":"Qi","year":"2015","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0345","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","article-title":"CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field","volume":"12","author":"Lee","year":"2016","journal-title":"J. Chem. Theory Comput."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115300_bb0350","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2026.115300_bb0355","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.colsurfb.2012.07.017","article-title":"Optimized nanoemulsifying systems with enhanced bioavailability of carvedilol","volume":"101","author":"Singh","year":"2013","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0360","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1208\/s12249-009-9192-7","article-title":"Preparation and evaluation of self-nanoemulsifying tablets of carvedilol","volume":"10","author":"Mahmoud","year":"2009","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115300_bb0365","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1208\/s12249-015-0440-8","article-title":"Development, optimization, and evaluation of carvedilol-loaded solid lipid nanoparticles for intranasal drug delivery","volume":"17","author":"Aboud","year":"2016","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115300_bb0370","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/10837450.2013.795169","article-title":"Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration","volume":"19","author":"Shah","year":"2014","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2026.115300_bb0375","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.addr.2016.04.007","article-title":"50 years of oral lipid-based formulations: provenance, progress and future perspectives","author":"Feeney","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.115300_bb0380","author":"020297s013lbl.pdf"},{"issue":"8","key":"10.1016\/j.jconrel.2026.115300_bb0390","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/(SICI)1522-2675(19990804)82:8<1211::AID-HLCA1211>3.0.CO;2-K","article-title":"Structure-lipophilicity relationships of neutral and protonated \u03b2-blockers, part I, intra- and intermolecular effects in isotropic solvent systems","volume":"82","author":"Caron","year":"1999","journal-title":"Helv. Chim. Acta"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115300_bb0395","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF00544245","article-title":"Pharmacokinetics and bioavailability of carvedilol, a vasodilating beta-blocker","volume":"33","author":"M\u00f6llendorff","year":"1987","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.115300_bb0405","article-title":"Development and bioequivalence of 3D-printed medication at the point-of-care: bridging the gap towards personalized medicine","author":"Lyousoufi","year":"2026","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115300_bb0410","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020259","article-title":"Can 3D printed tablets be bioequivalent and how to test it: a PBPK model based virtual bioequivalence study for ropinirole modified release tablets","volume":"16","author":"Shuklinova","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115300_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12010001","article-title":"In vitro and in vivo bioequivalence study of 3D-printed instant-dissolving Levetiracetam tablets and subsequent personalized dosing for Chinese children based on physiological pharmacokinetic modeling","volume":"14","author":"Li","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.115300_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125063","article-title":"In vivo pharmacokinetic study and PBPK modeling: comparison between 3D-printed nanocrystals and solid dispersions","volume":"669","author":"Lopez-Vidal","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115300_bb0425","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1007\/s13346-025-01868-y","article-title":"A framework for conducting clinical trials involving 3D printing of medicines at the point-of-care","volume":"15","author":"Parramon-Teixido","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115300_bb0430","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1002\/jps.23292","article-title":"Comparative pharmacokinetics studies of immediate- and modified-release formulations of glipizide in pigs and dogs","volume":"101","author":"Kulkarni","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115300_bb0435","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1067\/mhj.2002.121265","article-title":"Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters","volume":"143","author":"L\u00e4er","year":"2002","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115300_bb0440","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1365-2125.2007.03046.x","article-title":"Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure","volume":"65","author":"Albers","year":"2008","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926007042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:18:36Z","timestamp":1793337516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926007042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":83,"alternative-id":["S0168365926007042"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115300","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Absorption from 3D-printed pediatric carvedilol tablets: insights from in vitro, in vivo, and in silico approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115300","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115300"}}